Skip to menu Skip to content Skip to footer
Professor

Steve Deitelzweig

Email: 

Overview

Availability

Professor Steve Deitelzweig is:
Available for supervision

Works

Search Professor Steve Deitelzweig’s works on UQ eSpace

103 works between 1994 and 2023

1 - 20 of 103 works

2023

Journal Article

Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study

Deitelzweig, Steven, Keshishian, Allison, Kang, Amiee, Jenkins, Aaron, Atreja, Nipun, Schuler, Patricia, Jiang, Jenny, Yuce, Huseyin, Sun, Xiaoxi and Lip, Gregory Y.H. (2023). Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study. European Journal of Internal Medicine, 108, 37-42. doi: 10.1016/j.ejim.2022.10.021

Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study

2022

Journal Article

Correction: Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID‑19 in the United States: a retrospective cohort study (Journal of Thrombosis and Thrombolysis, (2022), 53, 4, (766-776), 10.1007/s11239-022-02644-2)

Deitelzweig, Steve, Luo, Xuemei, Nguyen, Jennifer L., Malhotra, Deepa, Emir, Birol, Russ, Cristina, Li, Xiaoyan, Lee, Theodore C., Ferri, Mauricio, Wiederkehr, Danny, Reimbaeva, Maya, Barnes, Geoffrey D. and Piazza, Gregory (2022). Correction: Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID‑19 in the United States: a retrospective cohort study (Journal of Thrombosis and Thrombolysis, (2022), 53, 4, (766-776), 10.1007/s11239-022-02644-2). Journal of Thrombosis and Thrombolysis, 54 (4), 696-696. doi: 10.1007/s11239-022-02708-3

Correction: Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID‑19 in the United States: a retrospective cohort study (Journal of Thrombosis and Thrombolysis, (2022), 53, 4, (766-776), 10.1007/s11239-022-02644-2)

2022

Journal Article

Payer formulary exclusions of apixaban: how patients respond and potential implications

Deitelzweig, Steven, Terasawa, Emi, Kang, Amiee, Atreja, Nipun, Hines, Dionne M., Noman, Ahmed and Luo, Xuemei (2022). Payer formulary exclusions of apixaban: how patients respond and potential implications. Current Medical Research and Opinion, 38 (11), 1-6. doi: 10.1080/03007995.2022.2128189

Payer formulary exclusions of apixaban: how patients respond and potential implications

2022

Journal Article

Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19

Deitelzweig, Steven, Zhu, Julia, Jiang, Jenny, Luo, Xuemei, Keshishian, Allison, Ferri, Mauricio, Rosenblatt, Lisa, Schuler, Patricia, Gutierrez, Cynthia and Dhamane, Amol D. (2022). Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19. Current Medical Research and Opinion, 38 (11), 1891-1896. doi: 10.1080/03007995.2022.2112871

Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19

2022

Journal Article

Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants

Lip, Gregory Y. H., Murphy, Richard R., Sahiar, Farhad, Ingall, Timothy J., Dhamane, Amol D., Ferri, Mauricio, Hlavacek, Patrick, Preib, Madison T., Keshishian, Allison, Russ, Cristina, Rosenblatt, Lisa, Yuce, Huseyin and Deitelzweig, Steven (2022). Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants. JAMA Network Open, 5 (8) e2229333, 1-12. doi: 10.1001/jamanetworkopen.2022.29333

Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants

2022

Journal Article

Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases

Lip, Gregory Y. H., Keshishian, Allison, Kang, Amiee, Luo, Xuemei, Atreja, Nipun, Zhang, Yan, Schuler, Patricia, Jiang, Jenny, Yuce, Huseyin and Deitelzweig, Steven (2022). Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases. Journal of Thrombosis and Thrombolysis, 54 (1), 33-46. doi: 10.1007/s11239-022-02660-2

Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases

2022

Journal Article

Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study

Deitelzweig, Steve, Luo, Xuemei, Nguyen, Jennifer L., Malhotra, Deepa, Emir, Birol, Russ, Cristina, Li, Xiaoyan, Lee, Theodore C., Ferri, Mauricio, Wiederkehr, Danny, Reimbaeva, Maya, Barnes, Geoffrey D. and Piazza, Gregory (2022). Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study. Journal of Thrombosis and Thrombolysis, 53 (4), 766-776. doi: 10.1007/s11239-022-02644-2

Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study

2022

Journal Article

Effectiveness and safety of apixaban versus warfarin in obese patients with nonvalvular atrial fibrillation enrolled in medicare and veteran affairs

Deitelzweig, Steve, Sah, Janvi, Kang, Amiee, Russ, Cristina, Preib, Madison, Dhamane, Amol D., Ratiu, Anna, Cato, Matthew, Alfred, Tamuno, Levi, Edi and Di Fusco, Manuela (2022). Effectiveness and safety of apixaban versus warfarin in obese patients with nonvalvular atrial fibrillation enrolled in medicare and veteran affairs. American Journal of Cardiology, 163, 43-49. doi: 10.1016/j.amjcard.2021.09.047

Effectiveness and safety of apixaban versus warfarin in obese patients with nonvalvular atrial fibrillation enrolled in medicare and veteran affairs

2021

Journal Article

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer

Deitelzweig, Steven, Keshishian, Allison V., Zhang, Yan, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Klem, Christian, Ferri, Mauricio, Jiang, Jenny, Yuce, Huseyin and Lip, Gregory Y.H. (2021). Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer. JACC: CardioOncology, 3 (3), 411-424. doi: 10.1016/j.jaccao.2021.06.004

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer

2021

Journal Article

Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy

Lip, Gregory Y. H., Keshishian, Allison, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Klem, Christian, Rosenblatt, Lisa, Mardekian, Jack, Jiang, Jenny, Yuce, Huseyin and Deitelzweig, Steven (2021). Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy. European Heart Journal - Cardiovascular Pharmacotherapy, 7 (5), 405-414. doi: 10.1093/ehjcvp/pvaa117

Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy

2021

Journal Article

Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients with High Risk of Gastrointestinal Bleeding

Lip, Gregory Y. H., Keshishian, Allison V., Zhang, Yan, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Klem, Christian, Ferri, Mauricio, Jiang, Jenny, Yuce, Huseyin and Deitelzweig, Steven (2021). Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients with High Risk of Gastrointestinal Bleeding. JAMA Network Open, 4 (8) e2120064, 1-14. doi: 10.1001/jamanetworkopen.2021.20064

Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients with High Risk of Gastrointestinal Bleeding

2021

Journal Article

Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity

Deitelzweig, Steven, Keshishian, Allison, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Klem, Christian, Rosenblatt, Lisa, Mardekian, Jack, Jiang, Jenny, Yuce, Huseyin and Lip, Gregory Y. H. (2021). Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity. Advances in Therapy, 38 (6), 3166-3184. doi: 10.1007/s12325-021-01724-8

Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity

2021

Journal Article

Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients

Deitelzweig, Steven, Keshishian, Allison, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Balachander, Neeraja, Rosenblatt, Lisa, Mardekian, Jack, Jiang, Jenny, Yuce, Huseyin and Lip, Gregory Y. H. (2021). Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients. Therapeutic Advances in Gastroenterology, 14. doi: 10.1177/1756284821997352

Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients

2021

Journal Article

Real-world persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis

Deitelzweig, Steven, Di Fusco, Manuela, Kang, Amiee, Savone, Mirko, Mokgokong, Ruth, Keshishian, Allison, Gutierrez, Cynthia and Cappelleri, Joseph C. (2021). Real-world persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis. Current Medical Research and Opinion, 37 (6), 891-902. doi: 10.1080/03007995.2021.1897555

Real-world persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis

2021

Journal Article

Response to a letter by Jolobe: ARISTOPHANES subgroup analysis of frail and older patients with NVAF receiving low doses of novel oral anticoagulants

Lip, G. Y. H. and Deitelzweig, S. B. (2021). Response to a letter by Jolobe: ARISTOPHANES subgroup analysis of frail and older patients with NVAF receiving low doses of novel oral anticoagulants. Journal of Internal Medicine, 290 (1), 221-222. doi: 10.1111/joim.13296

Response to a letter by Jolobe: ARISTOPHANES subgroup analysis of frail and older patients with NVAF receiving low doses of novel oral anticoagulants

2020

Journal Article

Frequency of venous thromboembolism in 6513 patients with COVID-19: A retrospective study

Hill, Jason B., Garcia, David, Crowther, Mark, Savage, Bryan, Peress, Shira, Chang, Kevin and Deitelzweig, Steven (2020). Frequency of venous thromboembolism in 6513 patients with COVID-19: A retrospective study. Blood Advances, 4 (21), 5373-5377. doi: 10.1182/bloodadvances.2020003083

Frequency of venous thromboembolism in 6513 patients with COVID-19: A retrospective study

2020

Journal Article

Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USA

Deitelzweig, Steven B., Lovelace, Belinda, Christoph, Mary, Lingohr-Smith, Melissa, Lin, Jay and Fermann, Gregory J. (2020). Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USA. Advances in Therapy, 37 (9), 3942-3953. doi: 10.1007/s12325-020-01440-9

Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USA

2020

Journal Article

Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study

Lip, G. Y.H., Keshishian, A. V., Kang, A. L., Dhamane, A. D., Luo, X., Li, X., Balachander, N., Rosenblatt, L., Mardekian, J., Pan, X., Di Fusco, M., Garcia Reeves, A. B., Yuce, H. and Deitelzweig, S. (2020). Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study. Journal of Internal Medicine, 289 (1) joim.13140, 42-52. doi: 10.1111/joim.13140

Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study

2020

Journal Article

Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study

Deitelzweig, Steve, Keshishian, Allison, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Li, Xiaoyan, Balachander, Neeraja, Rosenblatt, Lisa, Mardekian, Jack, Pan, Xianying, Di Fusco, Manuela, Reeves, Alessandra B. Garcia, Yuce, Huseyin and Lip, Gregory Y. H. (2020). Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study. Journal of Clinical Medicine, 9 (6) 1633, 1-25. doi: 10.3390/jcm9061633

Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study

2020

Journal Article

Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative

Barkoudah, Ebrahim, Piazza, Gregory, Hecht, Todd E. H., Grant, Paul, Deitelzweig, Steven, Fang, Margaret C., Fanikos, John, Kao, Cheng-Kai, Barnes, Geoffrey D., Chen, Thomas, Ramishvili, Tea, Schnipper, Jeffrey L., Goldstein, Jennifer N., Ruff, Christian T., Kaatz, Scott, Schwartz, Aviva, Connors, Jean M. and Goldhaber, Samuel Z. (2020). Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative. American Journal of Medicine, 133, 1-27. doi: 10.1016/j.amjmed.2019.12.001

Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative

Supervision

Availability

Professor Steve Deitelzweig is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Professor Steve Deitelzweig's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au